120 related articles for article (PubMed ID: 30065912)
21. Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy.
Zhou X; Wang X; Song Q; Yang H; Zhu X; Yu J; Song G; Di L; Ren J; Shao H; Lyerly HK
Int J Clin Pharmacol Ther; 2015 Nov; 53(11):914-22. PubMed ID: 26396136
[TBL] [Abstract][Full Text] [Related]
22.
Costa EFD; Lima TRP; Lopes-Aguiar L; Nogueira GAS; Visacri MB; Quintanilha JCF; Pincinato EC; Calonga L; Mariano FV; Altemani AMAM; Altemani JMC; Moriel P; Chone CT; Ramos CD; Lima CSP
Tumour Biol; 2020 Jul; 42(7):1010428320938494. PubMed ID: 32628088
[TBL] [Abstract][Full Text] [Related]
23. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
[TBL] [Abstract][Full Text] [Related]
24. SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer.
Huang L; Zhang T; Xie C; Liao X; Yu Q; Feng J; Ma H; Dai J; Li M; Chen J; Zang A; Wang Q; Ge S; Qin K; Cai J; Yuan X
PLoS One; 2013; 8(10):e77223. PubMed ID: 24143213
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of vascular endothelial growth factor on prognosis in osteosarcoma patients.
Dong-Ju Z; Ai-Ju X; Yun-Jiao T; Ming-Qiu Z
Pak J Med Sci; 2014 Sep; 30(5):1072-6. PubMed ID: 25225529
[TBL] [Abstract][Full Text] [Related]
26. The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen.
Geng N; Su J; Liu Z; Ding C; Xie S; Hu W
Technol Cancer Res Treat; 2021; 20():15330338211019433. PubMed ID: 34060368
[TBL] [Abstract][Full Text] [Related]
27. Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma.
Diekstra MH; Belaustegui A; Swen JJ; Boven E; Castellano D; Gelderblom H; Mathijssen RH; García-Donas J; Rodríguez-Antona C; Rini BI; Guchelaar HJ
Pharmacogenomics J; 2017 Jan; 17(1):42-46. PubMed ID: 26810136
[TBL] [Abstract][Full Text] [Related]
28. [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults.
Hawkins DS; Conrad EU; Butrynski JE; Schuetze SM; Eary JF
Cancer; 2009 Aug; 115(15):3519-25. PubMed ID: 19517457
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of the FAS and FASL genes and risk of breast cancer.
Wang W; Zheng Z; Yu W; Lin H; Cui B; Cao F
Oncol Lett; 2012 Mar; 3(3):625-628. PubMed ID: 22740964
[TBL] [Abstract][Full Text] [Related]
30. The association between the SNP rs763110 and the risk of gynecological cancer: a meta-analysis.
Zhou L; Zhang G; Zhou X; Li J
Biomed Pharmacother; 2015 Feb; 69():208-13. PubMed ID: 25661359
[TBL] [Abstract][Full Text] [Related]
31. [Association study of genetic variations in SLCO1B3 gene with prognosis in breast cancer patients treated with neoadjuvant chemotherapy of TA regimen].
Du ZL; Xu CS; Bian ZM; Peng MT; Li CB; Feng T; Xu XZ; Liu HJ; Zhang BL
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):587-593. PubMed ID: 31434449
[No Abstract] [Full Text] [Related]
32. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.
Zhang W; Li C; Wang J; He C
Hepatogastroenterology; 2012; 59(113):141-6. PubMed ID: 21940365
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
Sun Y; Wu Y; Li W; Kong Z; Zou X
Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355
[TBL] [Abstract][Full Text] [Related]
34. CDA and MTHFR polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine-based chemotherapy.
Liu D; Li X; Li X; Zhang M; Zhang J; Hou D; Tong Z; Dong M
Cancer Chemother Pharmacol; 2019 May; 83(5):939-949. PubMed ID: 30877365
[TBL] [Abstract][Full Text] [Related]
35. Haplotype analysis on relationship of ERCC2 and ERCC3 gene polymorphisms with osteosarcoma risk in Chinese young population.
Xu Q; Zhang Z; Sun W; Hu B
Mamm Genome; 2017 Jun; 28(5-6):227-233. PubMed ID: 28474168
[TBL] [Abstract][Full Text] [Related]
36. Association between genetic variants of membrane transporters and the risk of high-grade hematologic adverse events in a cohort of Mexican children with B-cell acute lymphoblastic leukemia.
Escalante-Bautista D; Cerecedo D; Jiménez-Hernández E; González-Torres C; Gaytán-Cervantes J; Núñez-Enríquez JC; Sepúlveda-Robles OA; De Ita M; Jiménez-Morales S; Sánchez-López JM; Mata-Rocha M; Torres-Nava JR; Martín-Trejo JA; Flores-Villegas LV; Gutiérrez-Rivera ML; Merino-Pasaye LE; Solís-Labastida KA; Miranda-Madrazo MR; Hernández-Echáurregui GA; Orozco-Ruíz D; Flores-Lujano J; Pérez-Saldívar ML; Mejía-Aranguré JM; Rosas-Vargas H
Front Oncol; 2023; 13():1276352. PubMed ID: 38269022
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
Zhao W; Hu L; Xu J; Shen H; Hu Z; Ma H; Shu Y; Shao Y; Yin Y
Cancer Chemother Pharmacol; 2013 May; 71(5):1287-95. PubMed ID: 23479135
[TBL] [Abstract][Full Text] [Related]
38. Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial.
Xie L; Xu J; Sun X; Guo W; Gu J; Liu K; Zheng B; Ren T; Huang Y; Tang X; Yan T; Yang R; Sun K; Shen D; Li Y
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32376724
[TBL] [Abstract][Full Text] [Related]
39. Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
Windsor RE; Strauss SJ; Kallis C; Wood NE; Whelan JS
Cancer; 2012 Apr; 118(7):1856-67. PubMed ID: 21887680
[TBL] [Abstract][Full Text] [Related]
40. Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study.
Caronia D; Patiño-Garcia A; Peréz-Martínez A; Pita G; Moreno LT; Zalacain-Díez M; Molina B; Colmenero I; Sierrasesúmaga L; Benítez J; Gonzalez-Neira A
PLoS One; 2011; 6(10):e26091. PubMed ID: 22016816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
